Treatment of Common Cold Patients with the Shi-Cha Capsule: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial

Table 3

Demographic data and baseline characteristics: intent-to-treat analysis.

	Group A (n = 114)	Group B (n = 117)	Group C (n = 115)	𝜒^2/𝐹	P values
Sex ratio (male/female)	71/43	76/41	75/40	0.263	0.877^†
Age (years) (mean ± SD)	35.98 ± 12.453	36.12 ± 12.465	35.64 ± 12.135	0.046	0.955^‡
Body weight (kg) (mean ± SD)	61.12 ± 10.514	60.23 ± 8.855	58.98 ± 9.827	1.387	0.251^‡
Height (cm) (mean ± SD)	164.63 ± 8.223	164.36 ± 7.750	164.11 ± 8.266	0.118	0.889^‡
Body temperature (°C) (mean ± SD)	36.95 ± 0.451	36.90 ± 0.481	36.98 ± 0.507	0.855	0.426^‡
Course (hours) (mean ± SD)	22.75 ± 11.096	24.21 ± 12.104	23.42 ± 11.477	0.516	0.772^¶
Main symptoms score (mean ± SD)
Avertion to cold	4.68 ± 1.741	4.59 ± 1.698	4.85 ± 1.713	1.477	0.478^¶
Nasal discharge	5.58 ± 1.991	5.26 ± 1.844	5.69 ± 2.002	2.836	0.242^¶
Minor symptoms score (mean ± SD)					0.478^¶
Arthralgia of extremities	1.33 ± 0.816	1.26 ± 0.770	1.28 ± 0.779	0.298	0.861^¶
Fever	0.45 ± 0.705	0.40 ± 0.732	0.49 ± 0.788	1.080	0.583^¶
Headache	1.01 ± 0.735	1.04 ± 0.781	0.97 ± 0.725	0.492	0.782^¶
Stuffy nose	1.66 ± 0.762	1.47 ± 0.677	1.64 ± 0.752	4.082	0.130^¶
Sneezing	1.38 ± 0.803	1.52 ± 0.690	1.42 ± 0.827	2.338	0.311^¶
Spiritlessness and weakness	1.18 ± 0.771	1.25 ± 0.684	1.29 ± 0.758	1.102	0.576^¶
Cumulative symptoms score (mean ± SD)	17.27 ± 4.700	16.79 ± 4.333	17.63 ± 4.979	0.962	0.383^‡

^†Chi-square test.
^‡One-way analysis of variance.
^¶Kruskal-Wallis H test.